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The focus of this paper is to review the data on the dietary sources 
of vitamin D, vitamin D supplementation and its bio-viability. Vi-
tamin D is a fat-soluble vitamin that plays an important role in hu-
man health. Low vitamin D levels (<75 nmol/l) have been reported 
worldwide in all age groups in recent years. Vitamin D deficiency 
is rising, mainly due to modern lifestyle and malabsorption dis-
orders. There are two main sources of vitamin D; dietary source 
which includes food of animal and plant origin as well as dietary 
supplements and endogenous synthesis under the UVB radiation in 
the skin. Dietary sources rich in vitamin D are mainly fish oil, sea 
fish, eggs, and margarines fortified with vitamin D. As the adequate 
intake of vitamin D is hard to achieve through the diet alone, dietary 
supplements of vitamin D are recommended. However, there are 
different factors influencing the bioavailability of vitamin D and are 
explained within this review article. There is no universal consent 
on the amount and the frequency of vitamin D supplementation. 
Furthermore, there is still missing information for better under-
standing the vitamin D absorption, bioavailability, and metabolism 
in human. Conclusion – A brief mini review article on vitamin D 
summarizes the current knowledge about dietary sources of vitamin 
D, vitamin D supplements, and its bio-viability. The best source of 
vitamin D is in vivo synthesis in the skin under the UVB radiation. 
The main dietary sources of vitamin D includes food of animal and 
plant origin. Adequate intake of vitamin D through the diet alone 
is hard to achieve, therefore vitamin D supplementation is recom-
mended.
Introduction 
Vitamin D, traditionally known as an essen-
tial nutrient, is a precursor of a potent steroid 
hormone that regulates a broad spectrum of 
physiological processes. It has many func-
tions in our body; it optimizes bone health, 
muscle function, cardiovascular system, im-
mune system, inhibits cancerogenesis, posi-
tively alters the gut microbiota, and many 
other (1–5).
The term “vitamin D” encompasses 
two molecules: cholecalciferol (vitamin D3; 
sourced from the skin exposure to ultravio-
let B radiation (UVB, usually sunlight) and 
food of animal origin) (6) and ergocalciferol 
(vitamin D2; source: food of plant origin) 
(7). It is believed that the cutaneous in vivo 
synthesis of vitamin D due to sun exposure 
is sufficient to meet daily vitamin D require-
ments (6). However, geographical reasons 
(latitude above/below 40° during from Octo-
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ber till April), socio-cultural reasons (cloth-
ing, strong sunscreen protection factor, inad-
equate nutrition such as vegan diet), religious 
reasons (veiled clothing), and  physiological 
reasons (skin pigmentation, age, obesity, 
chronic diseases, genetic abnormalities), may 
have a strong negative impact on synthesis of 
vitamin D in the skin (6–9).
Despite all the beneficial effects from vita-
min D, the World Health Organization rec-
ommends avoiding outdoor activities at mid-
day, especially between 10 a.m. and 4 p.m. 
(10). Nevertheless, the current policy of sun 
avoidance is creating probable harm for the 
general population, therefore different ex-
perts engage the World Health Organization, 
and other health entities in an immediate ef-
fort to define and quantify comprehensively 
the benefits and harms of sun exposure. Con-
crete recommendations for exposure at an in-
dividual level that are both safe and beneficial 
should be created (11).
Vitamin D metabolism may begin in the 
stomach where foods are subjected to acidic 
conditions and gastric enzymes. In the duo-
denum, digestive enzymes, e.g. proteases, 
amylases and lipases, continue to release vi-
tamin D from the food matrix. Vitamin D 
is assumed to follow the fate of lipids in the 
human upper gastrointestinal tract. It is also 
assumed that it is secreted in the chylomi-
crons and then transported to the liver (12). 
The absorption of vitamin D is facilitated 
by protein-mediated diffusion transport, de-
pending upon its concentration and the af-
finity of these transporters which may vary 
regarding the molecular forms of vitamin D 
(6). Partly also cholesterol transporter mech-
anisms might be involved in vitamin D ab-
sorption (13). Recently it was hypothesised 
that gut microbiota may also  have an impor-
tant role in vitamin D metabolism (14). Spe-
cific enzymes in the liver convert vitamin D 
into 25-hydroxyvitamin D3 (25(OH)D3), 
followed by the hydroxylation of 25(OH)
D3 into the 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3) which is the highly bio-ac-
tive form of vitamin D. Excess concentration 
of vitamin D in the blood stream is stored in 
adipose tissue and skeletal muscles (15). The 
level of 25(OH)D3 in the blood is an indi-
cator of vitamin D status of the patient. Its 
blood concentration depends on dietary in-
take (food and/or dietary supplements) and 
exposure to ultraviolet B radiation (UVB, 
usually sunlight) (15, 16). It would be hard 
to reach acceptable blood levels of vitamin D 
through the diet alone, so supplementation is 
advised for all age groups, especially during 
winter time above/below 40° latitude (Octo-
ber to April) when the production of vitamin 
D in the skin through the sun exposure is in-
sufficient (16–18).
However, there is a lack of standardised 
methods used to measure 25(OH)D3 sta-
tus, with different tests producing very dif-
ferent results (19). Some laboratories use 
conventional units (ng/ml), whereas other 
laboratories use international system (SI) 
units (nmol/l) for reporting 25(OH)D3 
concentration (conversion: 1 ng/ml = 2.496 
nmol/l). Endocrine Society established rang-
es of serum 25(OH)D3 concentration indi-
cating vitamin D deficiency (<20 ng/ml (<50 
nmol/l)), suboptimal status (20 – 30 ng/ml 
(50–75 nmol/l)) and target concentration 
for optimal vitamin D effects (30–50 ng/
ml (75–125 nmol/l)) (20, 21). Generally the 
concentration above the 125 nmol/l is not 
recommended as the long-term safety of such 
level is still unknown (22). However, in clini-
cal practice the phrase international unit (IU) 
for vitamin D intake is often used (conver-
sion: 1µg of vitamin D2 or D3 = 40 IU).
When vitamin D is supplemented, caution 
should be taken into account, because of pos-
sible toxicity of excessive oral vitamin D intake 
(6). However, the increasing use of vitamin D 
supplements has also seen a substantial in-
crease in the number of reports of vitamin D 
117
R. Kučan et al. ■ Dietary Sources of Vitamin D and Its Bio-Viability
intoxication (23). The features of vitamin D 
toxicity are mediated through hypercalcaemia, 
and symptoms range from mild, such as thirst 
and polyuria, to severe, including seizures, 
coma and death (24). It is found there is no 
risk for vitamin D toxicity from prolonged ex-
posure of UVB to the skin (25).  
To avoid the overdosing, European Food 
Safety Authority (EFSA) has set the Tolerable 
Upper Intake Levels (UL) for vitamin D in-
take. UL for adults (including pregnant and 
lactating women and adolescents aged 11-17 
years) is set at 100 µg/day (4,000 IU/day), for 
children aged 1-10 years at 50 µg/day (2,000 
IU/day), for infants aged 6-12 months at 35 
µg/day (1,400 IU/day), and for infants aged 
up to 6 months at 25 µg/day (1,000 IU/day) 
(26, 27).
This paper presents data from the scientif-
ic literature, and discusses the role of dietary 
sources of vitamin D, vitamin D supplemen-
tation, and its bio-viability. 
Dietary Sources of  Vitamin D
Dietary sources of vitamin D (vitamin D3 
and D2) generally account a very small 
amount of total vitamin D in the body (28). 
It was thought that bioavailability of vitamin 
D3 and D2 are not the same (29), but similar 
absorption efficiency was recently proven (6). 
Apart from vitamin D2 and vitamin D3, hy-
droxylated vitamin D (25(OH)D3) also con-
tributes significantly in dietary vitamin D, 
if food derives from animal origin. The dif-
ference in their polarity (polar-hydroxylated 
form and nonpolar-nonhydroxylated form) 
may contribute to their biological equiva-
lence inconsistency. It was found that bio-
availability of hydroxylated form (25(OH)
D3) is 10 times greater than that of the non 
hydroxylated forms (vitamin D2 and vitamin 
D3) vitamin D (6). Dietary sources rich in 
vitamin D are mainly fish oil, sea fish, eggs, 
and margarines fortified with vitamin D. A 
Table 1. Selected dietary sources of vitamin D (µg 
and IU/100 g) (30)
Food items µg/100 g IU/100 g
Fish oil
Cod liver oil 250 10000
Fishes
Smoked herring  32 1280
Salted mackerel 25 1000
Carp 25 1000
Eel 20 800
Salmon 16 640
Trout 15 600
Sole 15 600
Marinated herring 13 520
White fish 12 480
Canned salmon 12 480
Caviar 12 480
Sardines 11 440
Oysters 8 320
Tuna 5 200
Meat and meat products
Chicken liver, beef frankfurter 1.2 48
Turkey frankfurter 0.6 24
Veal, liver 0.3 12
Eggs
Yolk 5.6 224
Egg powder 5.0 200
Hens eggs, fresh or boiled 2.9 116
Milk and milk products
Butter 1.2 48
Cheese (45.0% milk fat)  1.0 40
Yoghurt (3.5% milk fat) 0.1 4
Pasteurized milk (3.5% milk 
fat) <0.1 <4
Sterilized milk (1.6% milk 
fat) <0.1 <4
Human milk <0.1 <4
Margarines
Becel pro-activ, maja 7.5 300
Rama klasik, back, creme 2.5 100
Plant based sources and vegetable drinks
Soy drink 1.4 56
Enriched rice drink 1.1 44
Mushrooms <0.1 <4
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compilation of vitamin D content of various 
food groups based on food composition data 
base (30) is provided in Table 1. Individuals 
who avoid consuming food of animal origin, 
such as vegetarians and vegans, might have 
lower 25(OH)D3 concentration in compari-
son with meat and fish eaters and therefore 
supplementation with vitamin D is advised 
(31, 32). Due to the lack of representative 
survey data, it is hard to estimate vitamin D 
daily intake accurately as food consumption 
patterns vary with social economic status. Be-
sides, the food database is often incomplete 
or lacking compositional data regarding vita-
min D concentration in a certain food/dish, 
which may result in lower dietary intake of 
vitamin D (33). However, the web-based ap-
plication’s assessment of dietary vitamin D 
intake, as well as other macro- and micronu-
trients of the patient, is very useful (34).
Vitamin D Supplementation
As adequate intake of vitamin D is hard to 
achieve through diet alone, even when for-
tified, the dietary supplements with vitamin 
D are recommended (35). However, there is 
data speculating the daily intake of vitamin 
D via food alone and in combination with di-
etary supplements. In most European coun-
tries, there seems to be a shortfall in achiev-
ing current vitamin D recommendations (7, 
18, 36–41). Vitamin D insufficiency, as well 
as deficiency, are well-documented, not only 
in Europe, but also in the general population 
around the world (16). It has been estimated 
that 80% of young people in Europe do not 
have adequate vitamin D intake (42). An ex-
ception is Finland, where dietary survey data 
indicates that recent national policies that 
include fortification and supplementation, 
coupled with a high habitual intake of oil-
rich fish, have resulted in an increase in vita-
min D intake, but this may not be a suitable 
strategy for all European population (36).
Calcitriol (1,25-hydroxyvitamin D), cal-
cidiol (25-dihydroxyvitamin D), cholecalcif-
erol (previtamin D3), ergocalciferol (previta-
min D2) and 7-dehydrocholecalciferol (pro-
vitamin D) are the major forms of vitamin 
D available on the market (6). Calcitriol is 
considered as the most active form of vitamin 
D, while calcidiol is an inactive form of vita-
min D which helps in the storage of vitamin 
D in tissues. Further, vitamin D2 and vitamin 
D3 are precursors of the active vitamin D (6).
The bioavailability of vitamin D in oil ve-
hicles is greater than that of powder-based ve-
hicles such as starch and cellulose. In contrast 
to this, the bioavailability of vitamin D in 
lactose capsule is higher than that of oily drop 
formulation. These supplements are made by 
changing physical properties (encapsulation 
of vitamin D) as well as chemical alteration 
of vitamin (vitamin D ester and salt) (6).
Currently, there is no universally ac-
cepted dose and frequency for the vitamin D 
supplementation among neonates, children, 
adolescents, pregnant and lactating women, 
adults and elderly – every country has their 
own recommendation regarding vitamin D 
supplementation (43). Interestingly, suffi-
cient vitamin D supplementation (4,000 IU/
day) of the lactating mother (38) is resulting 
in sufficient amount of vitamin D in human 
milk (400 IU/day) which is named as “shift-
ing the vitamin D paradigm” (44). However, 
further research on this field is needed before 
making such a strong recommendation for 
nursing mothers.
Benedik et al., 2013 summarized differ-
ent recommended vitamin D allowances for 
different age groups across the world; the rec-
ommended values varies from 200 IU/day in 
Australia and New Zealand for general popu-
lation (children to adults) and up to 2,000 
IU/day for pregnant and lactating mothers in 
Canada (43). This supports lactating mothers 
who take great pride in providing complete 
nutritional support to their breastfed infants. 
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However, maternal supplementation sup-
ports the health of mother and infant at once, 
nevertheless, current infant supplementation 
can leave the nursing mother with severe vi-
tamin D deficiency (45). Recent evidence 
supports the fact that low maternal vitamin 
D status is also associated with an increased 
risk of adverse pregnancy outcomes (46). 
However, EFSA set the adequate intake 
(AI) for vitamin D for infants aged 7–11 
months to be 10 µg/day (400 IU/day), for 
children aged 1–17 years and adults, includ-
ing pregnant and lactating women, set at 15 
µg/day (600 IU/day) (26), similar recom-
mendations have also other international 
institutions which are summarized elsewhere 
(47). For example in Austria, Germany and 
Switzerland they have the following recom-
mendations: 10 µg/day (400 IU/day) for 
0-12 month infants and 20 µg/day (800 
IU/day) for all others (children, teenagers, 
adults, pregnant and lactating women and 
elderly persons) (17). 
Particular population subsets, such as 
pregnant women, neonates, elderly persons 
(not adequately exposed to sun radiation), 
and patients (affected by fat metabolism and 
genetic variations in protein associated to vi-
tamin D uptake in intestine) are obligated to 
get vitamin D from supplements (48). 
Bioavailability of  Vitamin D from 
Food and Dietary Supplements 
Bioavailability is defined as the proportion 
of ingested amount (total vitamin in food) 
which ultimately ends up in the systemic cir-
culation (6). 
The acidic pH of gastric juice might af-
fect the bioavailability of vitamin D as well 
as protein-digesting enzymes (pepsin and 
trypsin) might be also involved in vitamin D 
absorption as they cleave vitamin D-binding 
proteins present in food and thus facilitate 
its release (6). Further, in duodenum diges-
tive enzymes (amylases, lipase and prote-
ase) continue the release of vitamin D from 
food matrix (6). Before absorption, vitamin 
D needs to be released from its matrix and 
get accessible to enterocytes. Recently it was 
thought that the bioavailability of vitamin D 
is affected by amount of ingested food and its 
complexity, but it was found that this does 
not impose any variation of bioavailability of 
vitamin D and it was found as effective as vi-
tamin D3 supplements (48, 49). 
The absorption of vitamin D supplements 
(vitamin D2 and vitamin D3) may be in-
creased up to 50%, if taken with a large meal 
(usually lunch). Increased absorption might 
be caused by high secretion of digestive en-
zymes (after a heavy meal) or due to some 
specific food components in the meal (fat) 
(35). When vitamin D was supplied through 
meat, its bioavailability was estimated to be 
60% as compared to vitamin D supplement. 
The vitamin D2 from UV radiated mush-
room was also tested, but their bioavailability 
was not compared with any other food ma-
trix (50, 51). However, it was demonstrated 
that the mushrooms containing vitamin D2 
have similar biological equivalence as supple-
mental vitamin D2 and vitamin D3 (53). 
Vitamin D absorption might be affect-
ed by the species of fatty acids of different 
chain length and degree of saturation. It is 
proposed that monounsaturated fatty acids 
increase the absorption of vitamin D more 
than polyunsaturated fatty acids (6, 53). Be-
sides, the amount of fat ingested does not af-
fect vitamin D absorption (12). Dietary fiber 
may also affect the bioavailability of vitamin 
D from food matrix, but more dedicated 
studies are required to understand the effect 
of dietary fibers on vitamin D bioavailabil-
ity (6). Nutrient status of the host might also 
have an important role on vitamin D absorp-
tion. Nutrients such as vitamin A, E and K, 
as well as different phytosterols, follow com-
mon pathway used in vitamin D uptake, 
R. Kučan et al. ■ Dietary Sources of Vitamin D and Its Bio-Viability
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which imposes competitions for vitamin D 
absorption in intestine. Vitamin A reduces 
absorption for 30%, vitamin E for 15-17% 
and phytosterols for 16-36% (6, 54). Person 
suffering from obesity consumes several an-
tiobesity drugs and fat substitutes to reduce 
the fat quantity in their diet, which impairs 
vitamin D absorption. Absorption of vitamin 
D is also low when using inhibitors of gastric 
and pancreatic lipases. In addition, different 
cholesterol derivatives from plant origin that 
are used for cholesterol absorption reduction 
may also affect the bioavailability of vitamin 
D (6). 
Conclusion
This review shows the main dietary sources 
of vitamin D, which includes food of animal 
and plant origin, as well as dietary supple-
ments. Adequate intake of vitamin D through 
the diet alone is hard to achieve, therefore vi-
tamin D supplementation is recommended. 
However, the best source of vitamin D is in 
vivo synthesis in the skin under the UVB ra-
diation. There are different factors influenc-
ing the bioavailability of vitamin D from 
food as well as from dietary supplements, but 
still, the fundamental mechanisms involved 
in vitamin D absorption are far from fully 
understood. Clinical studies with labelled vi-
tamin D (deuterated or 13 C) are needed to 
be done to assess the effects of different fac-
tors on vitamin D bioavailability. 
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